According to a recent announcement by Actos manufacturer Takeda Pharmaceuticals, over 96 percent of the eligible claimants have agreed to take part in the Actos product liability resolution program. Through the program, over 9,000 plaintiffs may receive compensation for their injuries without the uncertainty that exists in continued litigation. With over... Read more »

The latest Actos trial to begin in U.S. courts started on Thursday, August 27 in Las Vegas, under the direction of Judge Jerry Wiese II. Attorneys working for two southern Nevada claimants argue that their clients suffered severe side effects from the diabetes drug, including death. The trial is expected to... Read more »

Actos, a type 2 diabetes medication that has been linked in some studies to an increased risk of bladder cancer, is now suspected of raising the risk of other types of cancer as well. In addition to the much publicized Actos side effects to date, emerging research has determined that the... Read more »

On July 15, 2015, an Ohio resident and his wife filed an Actos bladder cancer lawsuit against both Takeda Pharmaceuticals and Eli Lilly, Inc. alleging severely inadequate warnings as to the increased risks associated with the Type II diabetes drug. The lawsuit, which was filed in United States District Court... Read more »

Twelve plaintiffs have filed lawsuits against Takeda Pharmaceuticals, claiming the drug caused their spouse or themselves to develop bladder cancer. Each Actos lawsuit will be added to the ongoing multidistrict litigation in the Western District of Louisiana. Actos is an oral diabetes medication used to control blood sugar levels in... Read more »

The federal judge presiding over thousands of Actos lawsuits that are currently consolidated in a multi-district litigation (MDL) recently issued a handful of case management orders. The orders are an apparent attempt to streamline the large, complex litigation, encourage large-scale settlement, and prevent duplication of thousands of state court Actos... Read more »

The drug Actos has been on the market since 1999, and was once one of the highest-grossing type 2 diabetes drugs available. Developed by drug maker Takeda Pharmaceuticals, Actos is becoming increasingly linked with the onset of deadly bladder cancer – and plaintiffs across the United States are accusing Takeda... Read more »

Earlier this month, a 79-year-old Philadelphia woman received a $2 million Actos lawsuit award for her bladder cancer claim. The jurors, after deliberating for more than five hours, found that the manufacturer was liable for Frances Wisniewski’s bladder cancer because it failed to warn her doctors about the cancer risk.... Read more »

The judge in one of the early Actos bladder cancer trials has upheld a record-breaking $9 billion punitive damages award against Takeda Pharmaceuticals and Eli Lilly, who recently attempted to have the Actos lawsuit award thrown out. U.S. District Judge Rebecca Doherty ruled that the jurors who assigned the award... Read more »

In a recent, and ongoing, federal lawsuit involving the diabetes drug Actos, manufacturer Takeda is now facing significant sanctions from U.S. District Court Judge Rebecca F. Doherty after a finding that it engaged in intentional and unlawful destruction of evidence tending to show it had knowledge of the dangers of... Read more »